This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Meridian Bioscience Inc (VIVO)

NASDAQ: Health Care

Company Cash Flow
Sep 2015 Sep 2014 Sep 2013 Sep 2012
Cash Flow From Operating Activities
Net Income (Loss) 0.00 34.74M 38.03M 33.37M
Operating Gains/Losses n.a. 6.00K 30.00K 359.00K
Extraordinary Gains / Losses n.a. 0.00 0.00 0.00
(Increase) Decrease In Receivables n.a. 0.00 0.00 0.00
(Increase) Decrease in Inventories n.a. 0.00 0.00 0.00
(Increase) Decrease In Other Current Assets n.a. -1.53M -3.49M 1.23M
(Decrease) Increase In Payables n.a. 0.00 0.00 0.00
(Decrease) Increase In Other Current Liabilities 0.00 -6.00M 2.67M 3.22M
(Increase) Decrease In Other Working Capital n.a. 0.00 0.00 0.00
Other Non-Cash Items n.a. 3.91M 1.86M -883.00K
Net Cash From Continuing Operations n.a. 38.26M 44.44M 42.45M
Net Cash From Discontinued Operations n.a. 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 0.00 38.26M 44.44M 42.45M
Sale of Property, Plant & Equipment n.a. 0.00 0.00 400.00K
Cash Used for Investing Activities
Sale of Short-Term Investments n.a. 0.00 0.00 0.00
Purchases of Property, Plant & Equipment 0.00 -7.00M -3.28M -4.83M
Acquisitions n.a. 0.00 0.00 0.00
Purchases of Short-Term Investments n.a. 0.00 0.00 0.00
Other Cash from Investing Activities 0.00 0.00 0.00 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities 0.00 -7.00M -3.28M -4.43M
Issuance of Debt 0.00 0.00 0.00 0.00
Cash Used for Financing Activities
Issuance of Capital Stock n.a. 1.01M 2.75M 552.00K
Repayment of Long-Term Debt 0.00 0.00 0.00 0.00
Repurchase of Capital Stock 0.00 0.00 0.00 0.00
Payment of Cash Dividends 0.00 -32.76M -31.35M -31.23M
Other Financing Charges, Net n.a. 0.00 0.00 0.00
Net Cash From Financing Activities 0.00 -31.75M -28.60M -30.67M
Effect of Exchange Rate Changes 0.00 -742.00K 132.00K 630.00K
Net Change in Cash & Cash Equivalents 0.00 -1.24M 12.69M 7.97M

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

VIVO Meridian Bioscience Inc

Chart of VIVO

Analysts Ratings for VIVO

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 1 1 1
Moderate Buy 1 1 0 0
Hold 3 3 3 3
Moderate Sell 0 0 0 0
Strong Sell 2 2 2 2

VIVO Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs